CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...

Great news for anyone whose big problem with hanging out on Twitter/X replacement Bluesky was all those dang words: An app developer working on the social media platform is now attempting to help ...

The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.